git SmartPolymorph

New patentable polymorph modifications of drugs and their co-crystals

The innovative company Smart Polymorph Technologies is conducting development of new patentable polymorph modifications of drugs and their co-crystals that are unattainable under normal synthesis conditions
Learn more

Technology

Development of polymorph modifications of well-known successful drugs to improve their properties, as well as to extend or renew patent protection
Development of polymorph modifications of new compounds that did not show the expected results in clinical studies to improve pharmacological properties and possible repositioning

STABILITY

Metastable crystalline and amorphous forms of the substance are physically stable for more than 3 years and have an ultra-high dissolution rate, thus increasing bioavailability

Properties

Our modifications have crystal and conformational polymorphism, at the expense of what:
  • increased therapeutic efficacy
  • reduced toxicity and / or side effects
  • increased dissolution rate and solubility
  • retention of solute properties for several years
  • possibility of creating new dosage forms
The technology allows you to co-crystallize several pharmaceutical substances at once or select compounds for co-crystallization